Confronto

Octreotide vs. Terlipressin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

83150-76-9

14636-12-5

Peso molecolare

1019.24 g/mol

1227.37 g/mol

Emivita

1.7 h

nessun dato

Sequenza

D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol)

nessun dato

Meccanismo d'azione

Octreotide

Octreotide is a cyclic octapeptide that selectively binds somatostatin-receptor subtypes SSTR2 and SSTR5. Via G-protein-coupled signalling, adenylyl cyclase is inhibited, reducing the secretion of multiple hormones (growth hormone, IGF-1, glucagon, insulin, VIP, serotonin). Structural stabilisation via a disulfide bridge and D-amino acids extends the half-life relative to natural somatostatin (minutes to several hours).

Terlipressin

Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Octreotide	Terlipressin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Octreotide and Terlipressin?: Octreotide is classified as "Ricerca (altro)", while Terlipressin is classified as "Ricerca (altro)". Octreotide: Synthetic octapeptide somatostatin analog with a longer half-life than endogenous somatostatin. FDA- and EMA-approved since the 1980s for acromegaly and neuroendocrine tumours. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Octreotide or Terlipressin?: The highest available evidence level is "RCT sull'uomo" for Octreotide and "RCT sull'uomo" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Octreotide and Terlipressin in Germany and the United States?: Germania: Octreotide — Su prescrizione, Terlipressin — Su prescrizione. Stati Uniti: Octreotide — Su prescrizione, Terlipressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Octreotide

Terlipressin

Germania

Su prescrizione

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Octreotide and Terlipressin?

Octreotide is classified as "Ricerca (altro)", while Terlipressin is classified as "Ricerca (altro)". Octreotide: Synthetic octapeptide somatostatin analog with a longer half-life than endogenous somatostatin. FDA- and EMA-approved since the 1980s for acromegaly and neuroendocrine tumours. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Octreotide or Terlipressin?

The highest available evidence level is "RCT sull'uomo" for Octreotide and "RCT sull'uomo" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Octreotide and Terlipressin in Germany and the United States?

Germania: Octreotide — Su prescrizione, Terlipressin — Su prescrizione. Stati Uniti: Octreotide — Su prescrizione, Terlipressin — Su prescrizione. These are factual summaries with source and review date on the individual pages.